Business Description
Britannia Life Sciences Inc
NAICS : 541714
SIC : 3741
ISIN : CA11042D1087
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.92 | |||||
Debt-to-EBITDA | 2.13 | |||||
Interest Coverage | 1.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.56 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 5.11 | |||||
9-Day RSI | 14.19 | |||||
14-Day RSI | 22.46 | |||||
6-1 Month Momentum % | 7.69 | |||||
12-1 Month Momentum % | -17.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 27.24 | |||||
Days Sales Outstanding | 84.27 | |||||
Days Payable | 520.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -4.43 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.29 | |||||
Operating Margin % | 16.49 | |||||
Net Margin % | 22.79 | |||||
FCF Margin % | 15.74 | |||||
ROE % | 23.58 | |||||
ROA % | 7.25 | |||||
ROIC % | 5.65 | |||||
ROC (Joel Greenblatt) % | 561.56 | |||||
ROCE % | 17.08 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 11.67 | |||||
PS Ratio | 1.52 | |||||
PB Ratio | 1.43 | |||||
Price-to-Free-Cash-Flow | 11.67 | |||||
Price-to-Operating-Cash-Flow | 7 | |||||
EV-to-EBIT | 4.86 | |||||
EV-to-EBITDA | 4.47 | |||||
EV-to-Revenue | 2.04 | |||||
EV-to-FCF | 14.36 | |||||
Earnings Yield (Greenblatt) % | 20.56 | |||||
FCF Yield % | 12.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Britannia Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 7.485 | ||
EPS (TTM) (C$) | 0.006 | ||
Beta | 0 | ||
Volatility % | 55.55 | ||
14-Day RSI | 22.46 | ||
14-Day ATR (C$) | 0.001398 | ||
20-Day SMA (C$) | 0.068 | ||
12-1 Month Momentum % | -17.65 | ||
52-Week Range (C$) | 0.03 - 0.13 | ||
Shares Outstanding (Mil) | 162.25 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Britannia Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Britannia Life Sciences Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Britannia Life Sciences Inc Frequently Asked Questions
What is Britannia Life Sciences Inc(XCNQ:BLAB)'s stock price today?
When is next earnings date of Britannia Life Sciences Inc(XCNQ:BLAB)?
Does Britannia Life Sciences Inc(XCNQ:BLAB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |